Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ong

Showing results (701-710 of 710) with videos related to

Pageof 71
Sort By:
You have reached the last page of results.This site can display upto 710 results.
MMWR. Morbidity and Mortality Weekly Report|March 3, 2022
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022Nicola P Klein, Melissa S Stockwell, Maria Demarco, et al.
MMWR. Morbidity and Mortality Weekly Report|February 17, 2022
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022Jill M Ferdinands, Suchitra Rao, Brian E Dixon, et al.
MMWR. Morbidity and Mortality Weekly Report|November 4, 2021
Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021Catherine H Bozio, Shaun J Grannis, Allison L Naleway, et al.
MMWR. Morbidity and Mortality Weekly Report|March 31, 2022
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022Karthik Natarajan, Namrata Prasad, Kristin Dascomb, et al.
MMWR. Morbidity and Mortality Weekly Report|November 4, 2021
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021Peter J Embi, Matthew E Levy, Allison L Naleway, et al.
MMWR. Morbidity and Mortality Weekly Report|February 27, 2025
Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years - VISION and IVY Networks, September 2024-January 2025Ruth Link-Gelles, Sean Chickery, Alexander Webber, et al.
Journal of Medical Genetics|July 26, 2020
Otitis media susceptibility and shifts in the head and neck microbiome due to <i>SPINK5</i> variantsDaniel N Frank, Arnaud P J Giese, Lena Hafren, et al.
MMWR. Morbidity and Mortality Weekly Report|February 27, 2025
Interim Estimates of 2024-2025 Seasonal Influenza Vaccine Effectiveness - Four Vaccine Effectiveness Networks, United States, October 2024-February 2025Aaron M Frutos, Seana Cleary, Emily L Reeves, et al.
American Journal of Human Genetics|November 8, 2018
FUT2 Variants Confer Susceptibility to Familial Otitis MediaRegie Lyn P Santos-Cortez, Charlotte M Chiong, Daniel N Frank, et al.
MMWR. Morbidity and Mortality Weekly Report|February 29, 2024
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years - VISION and IVY Networks, September 2023-January 2024Jennifer DeCuir, Amanda B Payne, Wesley H Self, et al.
Pageof 71

Showing results (701-710 of 710) with videos related to

Sort By:
Pageof 71
You have reached the last page of results.This site can display upto 710 results.
MMWR. Morbidity and Mortality Weekly Report|March 3, 2022
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022Nicola P Klein, Melissa S Stockwell, Maria Demarco, et al.
MMWR. Morbidity and Mortality Weekly Report|February 17, 2022
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022Jill M Ferdinands, Suchitra Rao, Brian E Dixon, et al.
MMWR. Morbidity and Mortality Weekly Report|November 4, 2021
Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021Catherine H Bozio, Shaun J Grannis, Allison L Naleway, et al.
MMWR. Morbidity and Mortality Weekly Report|March 31, 2022
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022Karthik Natarajan, Namrata Prasad, Kristin Dascomb, et al.
MMWR. Morbidity and Mortality Weekly Report|November 4, 2021
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021Peter J Embi, Matthew E Levy, Allison L Naleway, et al.
MMWR. Morbidity and Mortality Weekly Report|February 27, 2025
Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years - VISION and IVY Networks, September 2024-January 2025Ruth Link-Gelles, Sean Chickery, Alexander Webber, et al.
Journal of Medical Genetics|July 26, 2020
Otitis media susceptibility and shifts in the head and neck microbiome due to <i>SPINK5</i> variantsDaniel N Frank, Arnaud P J Giese, Lena Hafren, et al.
MMWR. Morbidity and Mortality Weekly Report|February 27, 2025
Interim Estimates of 2024-2025 Seasonal Influenza Vaccine Effectiveness - Four Vaccine Effectiveness Networks, United States, October 2024-February 2025Aaron M Frutos, Seana Cleary, Emily L Reeves, et al.
American Journal of Human Genetics|November 8, 2018
FUT2 Variants Confer Susceptibility to Familial Otitis MediaRegie Lyn P Santos-Cortez, Charlotte M Chiong, Daniel N Frank, et al.
MMWR. Morbidity and Mortality Weekly Report|February 29, 2024
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years - VISION and IVY Networks, September 2023-January 2024Jennifer DeCuir, Amanda B Payne, Wesley H Self, et al.
Pageof 71